Health Decisions CEO Explores High-Velocity Adaptive Clinical Research June 23 a

t DIA
Dr. Michael Rosenberg to present a session on implementing successful adaptive p
rograms for dramatically shorter, more efficient development timelines
Durham, NC, June 09, 2010 -- Health Decisions (www.HealthDec.com, Booth 1447), a
full-service clinical research organization (CRO) specializing in high-efficien
cy adaptive solutions, announces that President and CEO Michael Rosenberg, MD, M
PH will lead a paneled session June 23 at the DIA Annual Meeting in San Diego. T
he Practice of Adaptive Research will focus on the pragmatic aspects of planning
and managing complete adaptive programs – including the balance between mid-tri
al adjustments to both design and operations; the technology platform required t
o support these programs; and the broader implications of adaptive decision-maki
ng to the global pharmaceutical market.
According to Rosenberg, rising development costs, reimbursement pressures, and t
he global economic environment make the time- and cost-saving benefits of adapti
ve clinical research more important than ever. “Applying adaptive principles to
study design as well as day-to-day operations presents an immediate promise of a
dramatically faster, more efficient development pathway,” says Rosenberg. “We c
an eliminate poor candidates earlier, get good products to market faster, and ma
ke it financially attractive to focus on smaller, more individualized population
s, including individualized therapies.”
The Practice of Adaptive Research will include the following presentations from
industry experts:
“Operational Adaptations: Running Tighter, Faster Studies,” presented by Mike Fo
rd, director of data management at Health Decisions
“Drug Supply in Adaptive Studies,” presented Michael Krams, MD, vice president o
f Adaptive Trials and Applied Program Strategies at Wyeth
“Statistical Issues,” presented by Roger J. Lewis, MD, PhD, Professor of Medicin
e, Department of Emergency Medicine at Harbor UCLA Medical Center
“Financial Benefits of Adaptive,” presented by Michael Rosenberg, MD, MPH, presi
dent and CEO of Health Decisions
The Practice of Adaptive Research is part of the R&D Strategy (RD) track, and ta
kes place June 23 from 10:00 – 11:30 a.m. PST in Room 14B. To view the abstract,
please visit DIA online.
For media information, please contact Katie Hendrick, Marketing Specialist, by e
mail at khendrick@HealthDec.com or by phone at +1.919.967.1111 x116.
For sales and marketing information, please contact our Directors of Business De
velopment:
US: Uli Foley; Email: ufoley@HealthDec.com
Phone: 919.967.1111 x143; Mobile: 919.265.3500
Europe: Ernesto Encarnacion; Email: eencarnacion@HealthDec.com
Phone: +1.919.967.1111 x140: Mobile: +36.20.581.1669
About Health Decisions
Health Decisions (www.HealthDec.com) is a global clinical research organization
(CRO) committed to helping drug and device companies achieve greater success. Ou
r sponsors rely on us to help them prove the value of their pipelines both faste
r and with the smartest possible allocation of funds. Through Agile Clinical Dev
elopment—a strategic combination of adaptive design and adaptive operations—Heal
th Decisions optimizes every facet of clinical research from design protocol to
the most detailed day-to-day management, so sponsors can make the most of compet
itive market opportunities.
Health Decisions is headquartered in Durham, NC, with over twenty years of exper
ience helping sponsors achieve success in Phase I-IV trials across all major the
rapy areas. For more information, please visit the company's website at www.Heal
thDec.com.
About the DIA Annual Meeting
Hosted by the Drug Information Association, the DIA 45th Annual Meeting takes pl
ace June 21 – 25, 2009 at the San Diego Convention Center, California. The DIA A
nnual Meeting is the biopharmaceutical industry's largest, longest running, best
-value, global, multidisciplinary event. The 2009 program offers€learning opport
unities€for everyone€and€features the biggest names from industry, regulatory, a
nd academia. To learn more, visit DIA online.
About the Drug Information Association (DIA)
DIA serves more than 30,000 biopharmaceutical professionals from industry, acade
mia, and regulatory agencies worldwide. Through its domestic and international m
eetings, training courses, workshops and webinars, DIA provides a neutral global
forum for the exchange of information critical to the advancement of the drug d
iscovery and lifecycle management processes. Headquartered in Horsham, PA, USA,
and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing
, China, the Association is led by its volunteer-based Board of Directors and ex
ecutive management team. For more information, visit www.diahome.org or call 215
-442-6100.
Contact:
Katie Hendrick
Marketing Specialist
Health Decisions
Durham, NC
+1.919.967.1111
khendrick@HealthDec.com
http://www.HealthDec.com